- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02385357
Effect of a Protein-enriched Drink on Muscle Function (SPORTEUS)
March 10, 2015 updated by: Puleva Biotech
Effect of a Protein-enriched Drink on Muscle Function Recovery Following an Acute High Intensity Exercise Bout
There is no conclusive evidence about the effect of intake of protein-enriched drink after and acute high intensity exercise bout on muscle function and damage.
The investigators aimed to study the effect of a protein-enriched drink on muscle function recovery following an acute high intensity exercise bout.
The present counterbalanced, crossover, and double blind study will involve a total of 12 active men.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Participants will run downhill (-10%) during 30 min at a intensity equivalent to 75-80% of their maximum heart rate (previously determined).
After the exercise bout, participants will have either the placebo or the experimental drink.
The investigators will measure muscle function and damage-related parameters right after the exercise as well as the three following days.
This protocol will be repeated after a wash out period of 3 weeks, where the participants will have the other drink.
The investigators will control exercise and diet three weeks before study entry, during the experimental week as the investigators as during the wash out period.
Study Type
Interventional
Enrollment (Anticipated)
12
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Granada, Spain, 18004
- Recruiting
- Biosearch Life
-
Contact:
- Federico Lara, PhD
- Phone Number: 0034958240100
- Email: Federico.LaraVilloslada@puleva.es
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Recreational triathletes with 2 years of experience
- Maximum oxygen uptake : ≥55 ml/kg/min
- Fat mass: 8-20% measured by dual energy x-ray absorptiometry
- Not participating in another study
- Not having ergogenic aids
- Not participating in a weight loss program
- Normal electrocardiogram
- Participants must be capable and willing to provide consent, understand exclusion criteria and accept the randomized group assignment
Exclusion Criteria:
- History of cardiovascular disease
- Diabetes or hypertension
- Medication for hypertension, hyperlipidemia, hyperuricemia or other illness.
- Smoking
- Other significant medical conditions that are life-threatening or that can interfere with or be aggravated by exercise.
- Unwillingness to either complete the study requirements or to be randomized into control or training group.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Control
330 ml of commercial protein-enriched drink (2.5 g/100 ml of protein)
|
|
|
Experimental: Experimental
330 ml of protein-enriched drink (6 g/100 ml of protein)
|
Participants will drink 330 ml of a protein-enriched drink (6 g/ml of protein) after a high intensity exercise that induce muscle damage (30 min running downhill with a slope of -10º)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Isometric muscle strength
Time Frame: Change from pre- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink
|
Isometric muscle strength of lower limbs at 90% angle.
|
Change from pre- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle soreness of lower limbs self-reported by a visual anagogic scale and with an algometer score.
Time Frame: Change from post- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink
|
Muscle soreness of the lower limbs will be self-reported by a visual anagogic scale and with an algometer score.
|
Change from post- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink
|
|
Power output assessed with the 30sec. Wingate anaerobic test
Time Frame: Change from post- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink
|
Power output will be assessed with the 30sec.
Wingate anaerobic test.
|
Change from post- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink
|
|
Creatine kinase
Time Frame: Change from post- protein-enriched drink to 24, 48 hrs post- protein-enriched drink
|
Creatine kinase will be assessed after the protein-enriched drink to assess muscle recovery after a high intensity exercise bout
|
Change from post- protein-enriched drink to 24, 48 hrs post- protein-enriched drink
|
|
Urine Creatinine
Time Frame: Change from post- protein-enriched drink to 24, 48 hrs post- protein-enriched drink
|
Concentration of creatinine in urine will be assessed after the protein-enriched drink to assess muscle recovery after a high intensity exercise bout
|
Change from post- protein-enriched drink to 24, 48 hrs post- protein-enriched drink
|
|
Resting metabolic rate
Time Frame: Change from pre- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink
|
Change from pre- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink
|
|
|
Time limit (time that the participant is able to run 90% of his determined maximum aerobic velocity)
Time Frame: 24hrs after protein-enriched drink
|
We will measure the time that the participant is able to run 90% of his determined maximum aerobic velocity
|
24hrs after protein-enriched drink
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Federico Lara, PhD, Puleva Biotech
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2015
Primary Completion (Anticipated)
December 1, 2015
Study Completion (Anticipated)
December 1, 2015
Study Registration Dates
First Submitted
February 10, 2015
First Submitted That Met QC Criteria
March 10, 2015
First Posted (Estimate)
March 11, 2015
Study Record Updates
Last Update Posted (Estimate)
March 11, 2015
Last Update Submitted That Met QC Criteria
March 10, 2015
Last Verified
March 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Puleva
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contracture
-
C. R. BardRecruitingCapsular Contracture Associated With Breast Implant | Capsular Contracture Grade III | Capsular Contracture Grade IVUnited States
-
Dynasplint Systems, Inc.WithdrawnPronation ContractureUnited States
-
Southwest Hospital, ChinaUnknownAchilles Tendon ContractureChina
-
Mayo ClinicCompletedContracture of Elbow JointUnited States
-
Jeppe Lange, MDCompletedDupuytrens ContractureDenmark
-
University of MinnesotaRecruitingDupuytren Contracture | Dupuytren Disease of Finger | Dupuytren's Disease | Dupuytren Disease of Palm and Finger | Dupuytrens Contracture of Both Hands | Dupuytren's Disease of Palm of Right Hand | Dupuytren's Disease of Palm of Left Hand | Dupuytren Contracture of Right Palm | Dupuytren Contracture... and other conditionsUnited States
-
Bournemouth UniversityDorset HealthCare University NHS Foundation TrustCompletedContracture | Joint ContractureUnited Kingdom
-
Charles University, Czech RepublicCompleted
-
Anne Arundel Health System Research InstituteUnknownFlexion ContractureUnited States
-
Ottawa Hospital Research InstituteWithdrawn
Clinical Trials on Protein-enriched drink
-
King's College LondonLucozade Ribena SuntoryCompletedHealthy Men and WomenUnited Kingdom
-
King's College LondonLucozade Ribena SuntoryCompletedHealthy Men and WomenUnited Kingdom
-
KU LeuvenRecruitingMetabolic Syndrome | Body Composition | Blood Pressure | Anthropometry | Energy Expenditure | Metabolomics | Glycemia | LipaemiaBelgium
-
Wageningen University and ResearchAmsterdam UMC, location VUmc; Fonterra (Europe) Cooperatie U.A.; Carezzo B.V.; Hogeschool...Completed
-
Wageningen UniversityMaastricht University Medical Center; Top Institute Food and NutritionCompleted
-
Hospital General Universitario Gregorio MarañonInstituto de Salud Carlos III; European Regional Development Fund; Maternal,...UnknownProtein-Energy MalnutritionSpain
-
Maastricht University Medical CenterTop Institute Food and NutritionCompletedMuscle Loss in ElderlyNetherlands
-
Lund UniversityLandstinget i Kalmar LänTerminated
-
Mead Johnson NutritionCompletedCognitive Ability, GeneralChina
-
Clinica Universidad de Navarra, Universidad de...CompletedObesity | Weight Loss | ProteinSpain